Harmony Biosciences Holdings, Inc. HRMY
- clemizole hydrochloride — Dravet Syndrome Phase 3
- clemizole hydrochloride — Lennox-Gastaut Syndrome Phase 3
5HT-2 (1 companies · 2 programs)
Companies with an active program directed at 5HT-2.
Companies with an active program directed at 5HT-2.